{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:45:44Z","timestamp":1793303144017,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Pfizer Japan Inc.","award":["grant support"],"award-info":[{"award-number":["grant support"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00774-019-01073-1","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T16:02:38Z","timestamp":1577980958000},"page":"405-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Bazedoxifene improves renal function and increases renal phosphate excretion in patients with postmenopausal osteoporosis"],"prefix":"10.1007","volume":"38","author":[{"given":"Hideki","family":"Masaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-2631","authenticated-orcid":false,"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kurajoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takami","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00198-003-1435-y","volume":"14","author":"S Klawansky","year":"2003","unstructured":"Klawansky S, Komaroff E, Cavanaugh PF Jr, Mitchell DY, Gordon MJ, Connelly JE, Ross SD (2003) Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14:570\u2013576","journal-title":"Osteoporos Int"},{"key":"1073_CR2","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD (2016) Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis. PLoS ONE 11:e0158765","journal-title":"PLoS ONE"},{"key":"1073_CR3","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/ndt\/gfw354","volume":"31","author":"A Gasparini","year":"2016","unstructured":"Gasparini A, Evans M, Coresh J, Grams ME, Norin O, Qureshi AR, Runesson B, Barany P, Arnlov J, Jernberg T, Wettermark B, Elinder CG, Carrero JJ (2016) Prevalence and recognition of chronic kidney disease in Stockholm healthcare. Nephrol Dial Transplant 31:2086\u20132094","journal-title":"Nephrol Dial Transplant"},{"key":"1073_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00774-009-0080-8","volume":"27","author":"N Yoshimura","year":"2009","unstructured":"Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis\/osteoporosis against disability study. J Bone Miner Metab 27:620\u2013628","journal-title":"J Bone Miner Metab"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"e3427","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C (2012) Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ 344:e3427","journal-title":"BMJ"},{"key":"1073_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1681\/ASN.2006050546","volume":"18","author":"LF Fried","year":"2007","unstructured":"Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J, Newman AB, Robbins J (2007) Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 18:282\u2013286","journal-title":"J Am Soc Nephrol"},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/ndt\/gfn613","volume":"24","author":"A Covic","year":"2009","unstructured":"Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D (2009) Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24:1506\u20131523","journal-title":"Nephrol Dial Transplant"},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000197562","volume":"27","author":"M Kanbay","year":"2009","unstructured":"Kanbay M, Goldsmith D, Akcay A, Covic A (2009) Phosphate\u2014the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif 27:220\u2013230","journal-title":"Blood Purif"},{"key":"1073_CR9","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G, Cholesterol RE, Trial I (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627\u20132633","journal-title":"Circulation"},{"key":"1073_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/archinte.167.9.879","volume":"167","author":"R Dhingra","year":"2007","unstructured":"Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879\u2013885","journal-title":"Arch Intern Med"},{"key":"1073_CR11","doi-asserted-by":"publisher","first-page":"e36883","DOI":"10.1371\/journal.pone.0036883","volume":"7","author":"AL Cancela","year":"2012","unstructured":"Cancela AL, Santos RD, Titan SM, Goldenstein PT, Rochitte CE, Lemos PA, dos Reis LM, Graciolli FG, Jorgetti V, Moyses RM (2012) Phosphorus is associated with coronary artery disease in patients with preserved renal function. PLoS ONE 7:e36883","journal-title":"PLoS ONE"},{"key":"1073_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00223-015-0007-4","volume":"97","author":"M Yoda","year":"2015","unstructured":"Yoda M, Imanishi Y, Nagata Y, Ohara M, Yoda K, Yamada S, Mori K, Inaba M (2015) Teriparatide therapy reduces serum phosphate and intima-media thickness at the carotid wall artery in patients with osteoporosis. Calcif Tissue Int 97:32\u201339","journal-title":"Calcif Tissue Int"},{"key":"1073_CR13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.ajkd.2010.07.016","volume":"56","author":"MJ Landray","year":"2010","unstructured":"Landray MJ, Emberson JR, Blackwell L, Dasgupta T, Zakeri R, Morgan MD, Ferro CJ, Vickery S, Ayrton P, Nair D, Dalton RN, Lamb EJ, Baigent C, Townend JN, Wheeler DC (2010) Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis 56:1082\u20131094","journal-title":"Am J Kidney Dis"},{"key":"1073_CR14","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/ndt\/gfq787","volume":"26","author":"CD Chue","year":"2011","unstructured":"Chue CD, Edwards NC, Davis LJ, Steeds RP, Townend JN, Ferro CJ (2011) Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease. Nephrol Dial Transplant 26:2576\u20132582","journal-title":"Nephrol Dial Transplant"},{"key":"1073_CR15","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","volume":"26","author":"CM O'Seaghdha","year":"2011","unstructured":"O'Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS (2011) Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant 26:2885\u20132890","journal-title":"Nephrol Dial Transplant"},{"key":"1073_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","volume":"23","author":"SL Silverman","year":"2012","unstructured":"Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjaerg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD, Bazedoxifene Study G (2012) Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int 23:351\u2013363","journal-title":"Osteoporos Int"},{"key":"1073_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/13697137.2013.830605","volume":"17","author":"S Adami","year":"2014","unstructured":"Adami S, Palacios S, Rizzoli R, Levine AB, Sutradhar S, Chines AA (2014) The efficacy and safety of bazedoxifene in postmenopausal women by baseline kidney function status. Climacteric 17:273\u2013284","journal-title":"Climacteric"},{"key":"1073_CR18","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1681\/ASN.2007050555","volume":"19","author":"A Ishani","year":"2008","unstructured":"Ishani A, Blackwell T, Jamal SA, Cummings SR, Ensrud KE, Investigators M (2008) The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol 19:1430\u20131438","journal-title":"J Am Soc Nephrol"},{"key":"1073_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","volume":"61","author":"M Horio","year":"2013","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S, Collaborators Developing the Japanese Equation for Estimated GFR (2013) GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis 61:197\u2013203","journal-title":"Am J Kidney Dis"},{"key":"1073_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(73)93112-7","volume":"2","author":"AP Kenny","year":"1973","unstructured":"Kenny AP, Glen AC (1973) Tests of phosphate reabsorption. Lancet 2:158","journal-title":"Lancet"},{"key":"1073_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","volume":"16","author":"P Gao","year":"2001","unstructured":"Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL (2001) Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1\u201384: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605\u2013614","journal-title":"J Bone Miner Res"},{"key":"1073_CR22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis: the study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:984\u2013996","journal-title":"J Bone Miner Res"},{"key":"1073_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1507\/endocrj.K07E-027","volume":"55","author":"T Majima","year":"2008","unstructured":"Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K (2008) Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis. Endocr J 55:127\u2013134","journal-title":"Endocr J"},{"key":"1073_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00774-011-0325-1","volume":"30","author":"I Gorai","year":"2012","unstructured":"Gorai I, Hattori S, Tanaka Y, Iwaoki Y (2012) Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia. J Bone Miner Metab 30:349\u2013358","journal-title":"J Bone Miner Metab"},{"key":"1073_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bone.2012.12.001","volume":"53","author":"S Takeda","year":"2013","unstructured":"Takeda S, Sakai S, Shiraishi A, Koike N, Mihara M, Endo K (2013) Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats. Bone 53:167\u2013173","journal-title":"Bone"},{"key":"1073_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ki.2010.378","volume":"79","author":"ML Melamed","year":"2011","unstructured":"Melamed ML, Blackwell T, Neugarten J, Arnsten JH, Ensrud KE, Ishani A, Cummings SR, Silbiger SR (2011) Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int 79:241\u2013249","journal-title":"Kidney Int"},{"key":"1073_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1464-5491.2007.02165.x","volume":"24","author":"S Hadjadj","year":"2007","unstructured":"Hadjadj S, Gourdy P, Zaoui P, Guerci B, Roudaut N, Gautier JF, Chabin M, Mauco G, Ragot S, Group RS (2007) Effect of raloxifene\u2014a selective oestrogen receptor modulator\u2014on kidney function in post-menopausal women with type 2 diabetes: results from a randomized, placebo-controlled pilot trial. Diabet Med 24:906\u2013910","journal-title":"Diabet Med"},{"key":"1073_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/ki.2012.475","volume":"83","author":"Y Nishi","year":"2013","unstructured":"Nishi Y, Satoh M, Nagasu H, Kadoya H, Ihoriya C, Kidokoro K, Sasaki T, Kashihara N (2013) Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status. Kidney Int 83:662\u2013673","journal-title":"Kidney Int"},{"key":"1073_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1681\/ASN.2011010046","volume":"23","author":"H Delle","year":"2012","unstructured":"Delle H, Rocha JR, Cavaglieri RC, Vieira JM Jr, Malheiros DM, Noronha IL (2012) Antifibrotic effect of tamoxifen in a model of progressive renal disease. J Am Soc Nephrol 23:37\u201348","journal-title":"J Am Soc Nephrol"},{"key":"1073_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1291\/hypres.31.433","volume":"31","author":"E Imai","year":"2008","unstructured":"Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S (2008) Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 31:433\u2013441","journal-title":"Hypertens Res"},{"key":"1073_CR31","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.clinbiochem.2013.07.007","volume":"46","author":"J Helmersson-Karlqvist","year":"2013","unstructured":"Helmersson-Karlqvist J, Flodin M, Hansson LO, Larsson A (2013) The age related association is more pronounced for cystatin C estimated GFR than for creatinine estimated GFR in primary care patients. Clin Biochem 46:1761\u20131763","journal-title":"Clin Biochem"},{"key":"1073_CR32","first-page":"163","volume":"6","author":"B Uebelhart","year":"2009","unstructured":"Uebelhart B, Herrmann F, Rizzoli R (2009) Effects of the SERM raloxifene on calcium and phosphate metabolism in healthy middle-aged men. Clin Cases Miner Bone Metab 6:163\u2013168","journal-title":"Clin Cases Miner Bone Metab"},{"key":"1073_CR33","doi-asserted-by":"publisher","first-page":"E430","DOI":"10.1152\/ajpendo.00140.2004","volume":"288","author":"IM Dick","year":"2005","unstructured":"Dick IM, Devine A, Beilby J, Prince RL (2005) Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women. Am J Physiol Endocrinol Metab 288:E430\u2013E435","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1073_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1210\/jcem.85.3.6456","volume":"85","author":"H Uemura","year":"2000","unstructured":"Uemura H, Irahara M, Yoneda N, Yasui T, Genjida K, Miyamoto KI, Aono T, Takeda E (2000) Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab 85:1215\u20131219","journal-title":"J Clin Endocrinol Metab"},{"key":"1073_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"KDIGO","year":"2017","unstructured":"KDIGO (2017) Kidney disease: improving global outcomes (KDIGO) CKD-MBD update work group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2014mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"1073_CR36","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131305","journal-title":"N Engl J Med"},{"key":"1073_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.ajkd.2015.01.009","volume":"66","author":"J Da","year":"2015","unstructured":"Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y, Lv J, Zhang L, Wang H (2015) Serum phosphorus and progression of CKD and mortality: a meta-analysis of cohort studies. Am J Kidney Dis 66:258\u2013265","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-019-01073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-019-01073-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-019-01073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:55:46Z","timestamp":1609462546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-019-01073-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1007\/s00774-019-01073-1","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"15 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TM and MI has received grant support and lecture fees from Pfizer Japan Inc. YI, EM, TM, and MI have received lecture fees from Pfizer Japan Inc. HM, HN, YN, and KM have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}